Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BlackRock Science and Technology Trust stock logo
BST
BlackRock Science and Technology Trust
$47.50
-5.7%		$48.40
$34.87
▼
$51.30
N/AN/A99,455 shs99,918 shs
Bio-Techne Corp stock logo
TECH
Bio-Techne
$72.24
0.0%		$72.01
$43.19
▼
$72.62
$11.33B1.283.34 million shs1.50 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BlackRock Science and Technology Trust stock logo
BST
BlackRock Science and Technology Trust
+0.05%-0.91%+0.83%+4.19%+23.00%
Bio-Techne Corp stock logo
TECH
Bio-Techne
+0.21%-0.22%-0.18%+28.98%+40.99%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BlackRock Science and Technology Trust stock logo
BST
BlackRock Science and Technology Trust
$47.50
-5.7%		$48.40
$34.87
▼
$51.30
N/AN/A99,455 shs99,918 shs
Bio-Techne Corp stock logo
TECH
Bio-Techne
$72.24
0.0%		$72.01
$43.19
▼
$72.62
$11.33B1.283.34 million shs1.50 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BlackRock Science and Technology Trust stock logo
BST
BlackRock Science and Technology Trust
+0.05%-0.91%+0.83%+4.19%+23.00%
Bio-Techne Corp stock logo
TECH
Bio-Techne
+0.21%-0.22%-0.18%+28.98%+40.99%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BlackRock Science and Technology Trust stock logo
BST
BlackRock Science and Technology Trust
0.00
N/AN/AN/A
Bio-Techne Corp stock logo
TECH
Bio-Techne
2.12
Hold$68.92-4.58% Downside

Current Analyst Ratings Breakdown

Latest ENET, TECH, CBUY, and BST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/25/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/25/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
8/19/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
Benchmark Co. logo
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold
8/13/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$62.00 ➝ $73.00
8/4/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
7/9/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperform ➝ Sector Perform$62.00 ➝ $73.00
7/6/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
Evercore Inc logo
Evercore
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
6/30/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
Benchmark Co. logo
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold
6/29/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold$65.00 ➝ $73.00
6/26/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Neutral$70.00 ➝ $73.00
(Data available from 9/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BlackRock Science and Technology Trust stock logo
BST
BlackRock Science and Technology Trust
$905.23MN/AN/AN/AN/AN/A
Bio-Techne Corp stock logo
TECH
Bio-Techne
$1.22B9.32$2.35 per share30.72$13.47 per share5.36
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BlackRock Science and Technology Trust stock logo
BST
BlackRock Science and Technology Trust
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Bio-Techne Corp stock logo
TECH
Bio-Techne
$181.86M$1.1562.8136.308.5814.97%13.23%10.61%11/4/2026 (Estimated)

Latest ENET, TECH, CBUY, and BST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q4 2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.5190$0.52+$0.0010$0.35$314.63 million$321.19 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BlackRock Science and Technology Trust stock logo
BST
BlackRock Science and Technology Trust
$3.006.32%N/AN/AN/A
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.320.44%N/A27.83%N/A

Latest ENET, TECH, CBUY, and BST Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/10/2026
BlackRock Science and Technology Trust stock logo
BST
BlackRock Science and Technology Trust
monthly$0.256.05%12/11/202612/11/202612/22/2026
9/10/2026
BlackRock Science and Technology Trust stock logo
BST
BlackRock Science and Technology Trust
monthly$0.256.05%11/13/202611/13/202611/30/2026
9/10/2026
BlackRock Science and Technology Trust stock logo
BST
BlackRock Science and Technology Trust
monthly$0.256.05%10/15/202610/15/202610/30/2026
8/12/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
quarterly$0.650.44%8/24/20268/24/20269/4/2026
8/12/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
quarterly$0.080.44%8/17/20268/17/20268/28/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BlackRock Science and Technology Trust stock logo
BST
BlackRock Science and Technology Trust
N/AN/AN/A
Bio-Techne Corp stock logo
TECH
Bio-Techne
0.09
4.55
3.35

Institutional Ownership

CompanyInstitutional Ownership
BlackRock Science and Technology Trust stock logo
BST
BlackRock Science and Technology Trust
N/A
Bio-Techne Corp stock logo
TECH
Bio-Techne
98.95%

Insider Ownership

CompanyInsider Ownership
BlackRock Science and Technology Trust stock logo
BST
BlackRock Science and Technology Trust
N/A
Bio-Techne Corp stock logo
TECH
Bio-Techne
1.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
BlackRock Science and Technology Trust stock logo
BST
BlackRock Science and Technology Trust
17N/AN/ANot Optionable
Bio-Techne Corp stock logo
TECH
Bio-Techne
3,000156.82 million154.78 millionOptionable

Recent News About These Companies

Bio Techne (TECH) And The Valuation Case Behind Its Recent Rebound
September 15 at 8:14 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/bio-techne-tech-valuation-case-043053892.html
Bio-Techne Supplements Merger Proxy Amid Shareholder Litigation
September 14 at 5:50 PM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/bio-techne-supplements-merger-proxy-amid-shareholder-litigation?utm_source=marketbeat.com&utm_medium=referral
HB Wealth Management LLC Sells 24,595 Shares of Bio-Techne Corp $TECH
September 14 at 3:51 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-hb-wealth-management-llc-sells-24595-shares-of-bio-techne-corp-tech-2026-09-14/
California State Teachers Retirement System Boosts Stock Position in Bio-Techne Corp $TECH
September 14 at 3:11 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-california-state-teachers-retirement-system-boosts-stock-position-in-bio-techne-corp-tech-2026-09-14/
Wellington Management Group LLP Sells 5,109,880 Shares of Bio-Techne Corp $TECH
September 13 at 4:31 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-wellington-management-group-llp-sells-5109880-shares-of-bio-techne-corp-tech-2026-09-13/
Why Is Techne (TECH) Down 0.1% Since Last Earnings Report?
September 11, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2988553/why-is-techne-tech-down-0-1-since-last-earnings-report?cid=cs-stocknewsapi-ft-realtime_blog-2988553
WINTON GROUP Ltd Takes $4.75 Million Position in Bio-Techne Corp $TECH
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-winton-group-ltd-takes-475-million-position-in-bio-techne-corp-tech-2026-09-11/
Bio-Techne Corp $TECH Shares Acquired by Squarepoint Ops LLC
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bio-techne-corp-tech-shares-acquired-by-squarepoint-ops-llc-2026-09-11/
Bio-Techne Corp (NASDAQ:TECH) Given Average Rating of "Hold" by Analysts
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-bio-techne-corp-nasdaq-tech-given-average-rating-of-hold-by-analysts-2026-09-11/
Amundi Has $129.09 Million Position in Bio-Techne Corp $TECH
September 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-amundi-has-12909-million-position-in-bio-techne-corp-tech-2026-09-10/
Bio Techne
September 9, 2026  |  moneycontrol.comhttps://www.moneycontrol.com/us-markets/technical-analysis/biotechne/TECH/daily
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Bio-Techne Corporation (Nasdaq – TECH)
September 9, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/09/3358911/0/en/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-centerspace-nyse-csr-fulcrum-therapeutics-inc-nasdaq-fulc-weave-communications-inc-nyse-weav-bi.html
Maven Securities LTD Purchases Shares of 54,711 Bio-Techne Corp $TECH
September 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-maven-securities-ltd-purchases-shares-of-54711-bio-techne-corp-tech-2026-09-09/
Hsbc Holdings PLC Has $17.11 Million Stock Position in Bio-Techne Corp $TECH
September 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-hsbc-holdings-plc-has-1711-million-stock-position-in-bio-techne-corp-tech-2026-09-09/
Carmignac Gestion Purchases New Holdings in Bio-Techne Corp $TECH
September 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-carmignac-gestion-purchases-new-holdings-in-bio-techne-corp-tech-2026-09-08/
Public Employees Retirement System of Ohio Makes New Investment in Bio-Techne Corp $TECH
September 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-public-employees-retirement-system-of-ohio-makes-new-investment-in-bio-techne-corp-tech-2026-09-05/
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $38.22 Million Stock Position in Bio-Techne Corp $TECH
September 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-ubs-am-a-distinct-business-unit-of-ubs-asset-management-americas-llc-has-3822-million-stock-position-in-bio-techne-corp-tech-2026-09-04/
Alyeska Investment Group L.P. Sells 655,358 Shares of Bio-Techne Corp $TECH
September 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-alyeska-investment-group-lp-sells-655358-shares-of-bio-techne-corp-tech-2026-09-02/
Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals
September 1, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/bio-techne-achieves-science-based-targets-validation-and-reports-significant-progress-toward-climate-goals-302865718.html
Jupiter Topco LLC Makes New $4.82 Million Investment in Bio-Techne Corp $TECH
September 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-jupiter-topco-llc-makes-new-482-million-investment-in-bio-techne-corp-tech-2026-09-01/
Winners And Losers Of Q2: Bio-Techne (NASDAQ:TECH) Vs The Rest Of The Research Tools & Consumables Stocks
August 31, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/winners-losers-q2-bio-techne-210840276.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
A gold futuristic electric concept car parked on a street with a city skyline and capitol dome at dusk.
Tesla's Cybercab Launch Could Reshape Margins for Uber and Lyft
By Jeffrey Neal Johnson | August 19, 2026
Data center hallway with rows of server racks and cables, plus a monitoring room with computer screens in the background.
AI Token Costs Are Changing the Hardware vs. Software Debate
By Jeffrey Neal Johnson | September 6, 2026
Moderna logo displayed in a laboratory setting with a vaccine vial, petri dishes, and a microscope.
Moderna’s 177% Surge Has Investors Asking What Comes Next
By Sam Quirke | August 21, 2026
Gold-colored concept electric vehicle with a smooth, minimalist body parked outdoors near a building and tree.
Ride-Share Reckoning: Tesla Drives Into Uber's Lane
By Jeffrey Neal Johnson | September 7, 2026
MongoDB logo displayed in a server room aisle lined with illuminated data center racks.
MongoDB Is Surging—And the Next Catalyst Is Almost Here
By Thomas Hughes | August 24, 2026
BlackRock Science and Technology Trust stock logo

BlackRock Science and Technology Trust NYSE:BST

$47.50 -2.86 (-5.67%)
As of 03:30 PM Eastern
This is a fair market value price provided by Massive. Learn more.

BlackRock Science and Technology Trust is a closed ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests directly and indirectly through derivative such as options in public equity markets of countries across the globe. The fund seeks to invest in stocks of companies operating across the science and technology sector. It invests in dividend paying and growth stocks of companies operating across all market capitalizations. BlackRock Science and Technology Trust was formed on 28 October, 2014 and is domiciled in the United States.

Bio-Techne stock logo

Bio-Techne NASDAQ:TECH

$72.24 -0.04 (-0.05%)
As of 03:31 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas